{"id":"e79420da0b0d","type":"article","url":"https://hartvaat.nl/2017/02/14/cholesterolniveaus-en-de-rol-bij-het-identificeren-van-statinenontvangers/","title":"Cholesterolniveaus en de rol bij het identificeren van statinenontvangers","title_en":"Cholesterol Levels Should Play a More Important Role in Identifying Statin Recipients.","category":"cholesterol","category_label":"Cholesterol","professions":["cardioloog","huisarts","internist"],"tags":["anemie-ckd","dyslipidemie","ezetimibe","familiaire-hypercholesterolemie-screening","hdl-cholesterol","ldl-cholesterol","lipide-aferese","lipidenverlaging","lipoproteïne-a","lipoproteïne-a-therapeutisch-doel","niet-statine-therapie","obicetrapib","pcsk9-remmers","rosuvastatine","statines"],"journal":"Circulation","doi":"10.1161/CIRCULATIONAHA.116.022146","source_url":"https://doi.org/10.1161/CIRCULATIONAHA.116.022146","authors":["Paul N Durrington","Handrean Soran"],"significance":6,"published":"2017-02-14","source_date":"2017-02-14","image":"","kennis":["https://hartvaat.nl/kennis/lipiden/lpa-meten-wanneer-waarom/","https://hartvaat.nl/kennis/lipiden/lipidenmedicatie-bij-ckd/"],"congress":"","summary_en":"This analysis argued that cholesterol levels should play a more prominent role in identifying statin candidates, advocating for a lipid-based rather than purely risk-based approach to primary prevention treatment decisions.","created":"2026-07-03T10:26:33Z","updated":"2026-07-03T13:25:52Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Analyse die pleit voor een grotere rol van cholesterolniveaus bij het selecteren van patiënten voor statinetherapie. Relevant voor het debat tussen risicoscore-gebaseerde versus lipide-gebaseerde indicatiestelling.","abstract_original":""}